Syndicate

Latest California Healthline Stories

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?

Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.

At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’

Billings Clinic in Montana is past the tipping point as it looks for places to add intensive care unit beds and is on the cusp of rationing care to deal with the surge of sick covid patients in a state with significant anti-vaccination sentiment.

The Solution to Au Pairs’ Health Coverage Gaps May Be Simple: ACA Plans

Private agencies that bring young adults to the U.S. to care for children generally offer basic health insurance, but plans may exclude many types of necessary care. What the agencies might not mention is that au pairs are eligible to enroll in comprehensive coverage on the Affordable Care Act marketplaces and likely qualify for premium subsidies that would make the insurance affordable.

Congress Cites KHN Investigation in Probe of National Academies

The House oversight committee is requesting conflict-of-interest disclosure forms from a National Academies committee studying organ transplants. KHN previously reported on apparent conflicts among members of a committee studying drug waste. 

California’s Reboot of Troubled Medi-Cal Puts Pressure on Health Plans

The nine commercial insurers in Medi-Cal must reapply by submitting bids for new contracts. The state hopes the process will improve care for low-income residents and tighten accountability, something critics say has been missing.